作者: A NIEPONICE , L SOLETTI , J GUAN , B DEASY , J HUARD
DOI: 10.1016/J.BIOMATERIALS.2007.10.044
关键词: Viability assay 、 Biomedical engineering 、 In vitro 、 Stem cell 、 CD34 、 Myosin 、 Doubling time 、 Blood vessel prosthesis 、 Tissue engineering 、 Materials science
摘要: There is a clinical need for a tissue-engineered vascular graft (TEVG), and combining stem cells with biodegradable tubular scaffolds appears to be a promising approach. The goal of …